Seelaus Asset Management’s AstraZeneca AZN Stock Holding History

Seelaus Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Buy	+1,120	New	+$211K	0.15%	188
2022 Q3	–	Sell	-1,755	Closed	-$232K	–	220
2022 Q2	$232K	Buy	1,755 +192	+12%	+$25.2K	0.17%	168
2022 Q1	$207K	Buy	+1,563	New	+$187K	0.12%	228

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Seelaus Asset Management's AZN Position: Q2 2026 in Review

Seelaus Asset Management opened a new position in AstraZeneca (AZN) in Q2 2026: 1,120 shares worth $212K. The stake represents 0.15% of the portfolio and ranks #188 among its holdings. This is a return to the name: Seelaus Asset Management previously reported a position in AZN as recently as Q2 2022.

Seelaus Asset Management first reported a position in AZN in Q1 2022 and has held it in 3 quarters since. The position peaked at $232K in Q2 2022. 213 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Seelaus Asset Management held 1,120 shares of AstraZeneca worth $212K as of Q2 2026.
AstraZeneca was a new Seelaus Asset Management position in Q2 2026.
AstraZeneca made up 0.15% of Seelaus Asset Management's portfolio in Q2 2026, its #188 holding.
Seelaus Asset Management first reported a position in AstraZeneca in Q1 2022 and has held it in 3 quarters since.
Seelaus Asset Management's AstraZeneca position peaked at $232K in Q2 2022.
213 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.